Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim Immunomodulation in Young Adult ITP
NCT02760251Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Apr 2016
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of romiplostim in primary immune thrombocytopenia (ITP), sponsored by University Hospital Basel. Started Apr 2016; status: completed.
02
Drugs
romiplostim
03
Conditions
primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT02760251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760251.